Motegrity (Prucalopride) Dosing
The standard adult dose of Motegrity is 2 mg once daily, with a reduction to 1 mg once daily required only in patients with severe renal impairment (creatinine clearance <30 mL/min). 1
Standard Adult Dosing
- 2 mg once daily for adults with chronic idiopathic constipation 2
- Can be taken with or without food 1
- This is the maximum recommended dose 2
Dose Adjustments for Renal Impairment
The dosing algorithm based on renal function is straightforward:
- No adjustment needed for mild to moderate renal impairment (CrCl ≥30 mL/min) 1
- Reduce to 1 mg once daily for severe renal impairment (CrCl <30 mL/min) 2, 1
- Avoid use in end-stage renal disease requiring dialysis 1
This recommendation is based on pharmacokinetic data showing that patients with severe renal impairment have 2.3-fold higher drug exposure compared to those with normal renal function 3. The renal clearance pathway is significantly compromised in severe renal impairment, necessitating dose reduction to prevent excessive drug accumulation.
Age Considerations
No dose adjustment is required based on age alone 1. The efficacy and safety profile in patients ≥65 years is comparable to younger adults 2. However, elderly patients should have their dose adjusted based on renal function rather than age, as the higher drug exposure observed in elderly subjects is related to decreased renal function, not age itself 1.
In clinical trials, 15% of patients were ≥65 years and 5% were ≥75 years, with no overall differences in safety or effectiveness compared to younger patients 1.
Hepatic Impairment
No specific dose adjustment is provided for hepatic impairment in the FDA labeling 1. However, prucalopride is contraindicated in patients with active inflammatory bowel disease (Crohn's disease, ulcerative colitis) and toxic megacolon/megarectum 2.
Clinical Pearls
The 1-2 mg daily dosing range mentioned in guidelines 2 reflects the option to start at 1 mg in patients where tolerability is a concern, but 2 mg once daily is the standard therapeutic dose that demonstrated efficacy in clinical trials 2. Studies showed no additional benefit with 4 mg daily compared to 2 mg daily 4.
Common Pitfalls to Avoid:
- Don't use higher than 2 mg daily - this is the maximum recommended dose with no additional benefit 2
- Don't forget to assess renal function before prescribing, especially in elderly patients where decreased renal function may not be clinically obvious 1
- Don't continue at 2 mg in severe renal impairment - the 2.3-fold increase in drug exposure creates unnecessary risk of adverse effects 3
Side Effect Timeline:
Most adverse events (headache, nausea, diarrhea) occur within the first week and typically resolve within a few days 2. This transient nature should be communicated to patients to improve adherence. Five percent of patients discontinued due to side effects in clinical trials 2.